Investor Type | Firm |
Industries | BioTech • A.I. (& Big Data) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Pre-seed, Series A, Series B, Seed |
Investing | United States • United Kingdom • Germany • Netherlands • Belgium |
Investment Range | $11,000,000 - $65,000,000 |
Investment Sweet Spot | $25,000,000 |
Assets Under Management | $260,000,000 |
EQT Life Sciences is a purpose-driven global investment organization focusing on the life sciences sector. They cater to various industries such as BioTech, A.I. (& Big Data), HealthTech (& Fitness), Medical Devices (& Hospital Services), Healthcare (& Wellness), and Pharmaceutical (& Medicine). Their investment strategy is comprehensive and dynamic, encompassing new start-ups at the pre-seed stage and extending support up to Series B capital raisings. With assets under management totaling approximately 260 million USD, they offer financial investment ranging from a minimum of 11 million USD to a maximum of 65 million USD, focusing on a sweet spot of around 25 million USD for investments. As part of the EQT network, they pride themselves on contributing to the sectors they serve by providing not just funding but also strategic support and access to a broad network. The team at EQT Life Sciences comprises industry experts including Vice President Ishaan Tewarie, who brings in-depth knowledge and expertise with his background in predictive analytics for neurosurgery and prior experience as an investment consultant. EQT Life Sciences leverages EQT's wider digitalization and governance practices to bolster portfolio companies and drive innovation across the life sciences ecosystem. Their commitment to sustainability and responsible investment is integral to their operations, aligning with their core values and mission to invest with a long-term perspective in companies that can make a positive difference.